Recall: Accupril Tablets
May 2022Pharmacy Updates
Pfizer is recalling batches of Accupril tablets (Quinapril HCl – 10 mg, 20 mg, and 40 mg) due to the presence of a nitrosamine, Nnitrosoquinapril, that was observed in recent testing at levels above the Acceptable Daily Intake (ADI) level. Read the full text of the Accupril Tablets recall.
Recent Announcements
Understanding MP.PA.147
Understanding changes to the Diagnostic and Surveillance Colonoscopy, 18 Years Old and Older – MP.PA.147 policyJul. 2025Important Notices
Understanding MP.PA.147
Understanding changes to the Diagnostic and Surveillance Colonoscopy, 18 Years Old and Older – MP.PA.147 policyJul. 2025Important Notices
Register for the Oral Health in Your Pediatric Office CME -accredited webinar
Please join us for a live, CME-accredited webinar on Wednesday, Sept. 10 from noon to 1 p.m. that will provide an overview of oral health in your pediatric office. Providers with a(n) MD/DO, PA, CRNP, RN, or LPN may also apply for topical fluoride certification after completion of this course.Jun. 2025Education/Webinars